| 1 | Dupilumab | Dupilumab | 1件: D10354D10354 💬 | IL4R1件: IL4R 💬 | Cytokine-cytokine receptor interaction8件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation | 0514件: 51, 98, 160, 162 💬 | 
| 2 | Dupilumab (blinded) | Dupilumab | 1件: D10354D10354 💬 | IL4R1件: IL4R 💬 | Cytokine-cytokine receptor interaction8件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation | 0981件: 98 💬 | 
| 3 | Dupilumab (open-label) | Dupilumab | 1件: D10354D10354 💬 | IL4R1件: IL4R 💬 | Cytokine-cytokine receptor interaction8件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation | 0981件: 98 💬 | 
| 4 | Dupilumab 300mg solution for injection | Dupilumab | 1件: D10354D10354 💬 | IL4R1件: IL4R 💬 | Cytokine-cytokine receptor interaction8件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation | 0511件: 51 💬 | 
| 5 | Dupilumab prefilled syringe | Dupilumab | 1件: D10354D10354 💬 | IL4R1件: IL4R 💬 | Cytokine-cytokine receptor interaction8件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation | 1601件: 160 💬 | 
| 6 | Dupixent | - | - | - | - | 0983件: 98, 160, 162 💬 |